Why is Senores Pharma. falling/rising?

As of 03-Sep, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 712.00, which reflects a rise of Rs 15.2 or 2.18%. The stock has shown strong performance, with a 1-week return of +0.98% and a 1-month return of +6.82%, significantly outperforming the Sensex, which has seen a decline of -0.27% and -0.04% respectively during the same periods. Additionally, the stock is trading above all its moving averages, indicating a bullish trend. Positive financial indicators include a substantial growth in net sales and operating profit, with the latest quarterly results showing a 100.5% increase in net sales and the highest profit after tax recorded at Rs 2.70 crore. However, there are concerns regarding falling investor participation, as delivery volume has decreased by nearly 30% against the 5-day average, and institutional investors have reduced their stake slightly.
In the broader market context, Senores Pharmaceuticals' recent performance contrasts sharply with the Sensex, which has shown negative returns over the same periods. The stock's year-to-date return of +25.15% significantly outpaces the Sensex's +3.11%, highlighting its strong relative strength. Despite the positive growth metrics, the stock faces challenges such as a high price-to-book value ratio and declining institutional interest, which may impact future performance. The combination of strong sales growth and a favorable trading position suggests a positive outlook, but the reduced participation from institutional investors could pose risks moving forward.